Mayo Clinic researchers have identified a molecular mechanism that enables cancer cells and disease-causing pathogens to weaken T-cell responses, potentially...

Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy have reported that a single...

For patients with metastatic colorectal cancer, adding high-dose vitamin D to standard treatment did not significantly extend the time before...

Retinoblastoma, the most common malignant eye tumour in children, has become a new focus of research into the regulatory DNA...

A molecular switch that controls both bone destruction and bone formation may offer a new way to treat postmenopausal osteoporosis,...

For decades, mammary stem cells have been portrayed as the hidden architects of the breast: rare, self-renewing cells capable of...

Cancer-associated cachexia, the wasting syndrome that erodes muscle, fat and physical resilience in many people with advanced cancer, has long...

A new systematic review and meta-analysis is set to examine one of the most complex questions in modern public health:...

A new study describes a high-throughput strategy for engineering bispecific antibodies that could help macrophages destroy malignant B cells more...

WASHINGTON — A combination of two immunotherapy drugs produced substantially higher rates of tumor eradication when added to chemotherapy before...